Vivani的动态

Transcript

At Providing Medical, we are focused on the human health applications of our technology and our products. But we can't forget that an increasing part of our culture nowadays is treating a pet as part of one's family. And the amount that people care for their pets and are willing to invest in their pets health has only been increasing dramatically over the past several years. As such, we have engaged in a partnership with an animal health company called Oakhaven Pharmaceuticals, with whom we are. Collaboratively developing a version of our GLP One implant initially for the treatment of obesity and type 2 diabetes in companion felines. As it turns out, cats are notoriously difficult to dose and they have a very high prevalence of developing type 2 diabetes. And we are excited about the opportunity for our technology to help our animal friends as well.